CPK Q1 2026 Earnings Earnings Beat Estimates Amidst Operational Strength UTI Q1 2026 Earnings EPS Misses Estimates but Stock Climbs on Positive Indicators ERAS Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Climbs OPRT Q1 2026 Earnings EPS Surpasses Estimates by 243 Despite Stock Decline Chord Energy CHRD Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Efficiency Gains Novo Nordisk AS NVO Q1 2026 Earnings Strong EPS Beat Driven by Obesity and Diabetes Portfolio